More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…
Read More
Genomic Mapping Reveals Rapid Growth and Early Origins of Chronic Myeloid Leukemia Years Before Clinical Diagnosis
A landmark study published in the journal Nature has fundamentally altered the scientific understanding of chronic myeloid leukemia (CML), revealing…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
MIT Engineers Discover Exercise Stimulates Nerve Growth Through Biochemical and Physical Signaling
The long-standing medical consensus that physical activity bolsters the human body has reached a new frontier as researchers at the…
Read More
Study Reveals Explosive Growth Rates of Chronic Myeloid Leukemia Years Before Clinical Diagnosis and Identifies Factors Influencing Treatment Response
Chronic myeloid leukemia (CML), a malignancy of the white blood cells characterized by the presence of the Philadelphia chromosome, has…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
Johnson & Johnson is intensifying its efforts to expand the market footprint of Spravato (esketamine) for treatment-resistant depression (TRD), leveraging…
Read More
Unveiling the Explosive Origins of Chronic Myeloid Leukemia: New Genomic Research Reveals Rapid Pre-Diagnostic Growth and Treatment Implications
In a landmark study that challenges long-standing assumptions about the progression of blood cancers, researchers from the Wellcome Sanger Institute…
Read More
Lifelong Cognitive Growth: Landmark UT Dallas Study Challenges Traditional Notions of Age-Related Mental Decline
A comprehensive three-year study conducted by researchers at The University of Texas at Dallas’ Center for BrainHealth (CBH) has provided…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…
Read More
Innovative targeted protein degradation strategy suppresses tumor growth
Researchers at Northwestern Medicine (IL, USA) have announced the successful development of novel synthetic biomolecular condensates capable of degrading intracellular…
Read More
